Overexpression of MiR-141 and MiR-126 Distinguishes Metastatic Castration Resistant Prostate Cancer (mCRPC) From Localized Prostate Cancer (PCa) and Controls in Human Plasma

被引：1
|
作者：
Macfarlane, R. J. [1 ]
Watahiki, A. [2 ]
Wang, Y. Z. [2 ]
Chi, K. N. [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)70746-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [1] Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
    A. H. Zedan
    P. J. S. Osther
    J. Assenholt
    J. S. Madsen
    T. F. Hansen
    Scientific Reports, 10
  • [2] Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
    Zedan, A. H.
    Osther, P. J. S.
    Assenholt, J.
    Madsen, J. S.
    Hansen, T. F.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Expression of the metastatic prostate cancer biomarker miR-141 in prostate biopsy tissues
    Gaston, Sandra
    Kishawi, Iman
    Guerra, Andrew
    Cheng Yulan
    Nadadur, Rangarajan
    Kearney, Michael
    Meltzer, Stephen
    Pinsky, Paul
    Sorbara, Lynn
    Srivastava, Sudhir
    Gary, Kearney
    CANCER RESEARCH, 2009, 69
  • [4] miR-141 and miR-375 expression in plasma samples from Bulgarian prostate cancer patients and controls
    Kachakova, D.
    Popov, E.
    Mitkova, A.
    Popov, I.
    Vlahova, A.
    Dikov, T.
    Christova, S.
    Slavov, C.
    Mitev, V.
    Kaneva, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S95 - S95
  • [5] Androgen Stimulation of PCA3 and miR-141 and Their Release from Prostate Cancer Cells
    Gezer, Ugur
    Tiryakioglu, Duygu
    Bilgin, Elif
    Dalay, Nejat
    Holdenrieder, Stefan
    CELL JOURNAL, 2015, 16 (04) : 488 - 493
  • [6] Aurora A in Metastatic Castration Resistant Prostate Cancer (mCRPC)
    Rodrigues, Daniel Nava
    Mehra, Niven
    Figueiredo, Ines
    Crespo, Mateus
    Riisnaes, Ruth
    Miranda, Susana A. A.
    Ferreira, Ana
    Tunariu, Nina
    Perez-Lopez, Raquel
    Boysen, Gunther
    Sharp, Adam
    Bianchini, Diletta
    Kolinsky, Michael
    Rescigno, Pasquale
    Zafeiriou, Zafetris
    Mateo, Joaquin
    De Bono, Johann S.
    MODERN PATHOLOGY, 2016, 29 : 251A - 251A
  • [7] Aurora A in Metastatic Castration Resistant Prostate Cancer (mCRPC)
    Rodrigues, Daniel Nava
    Mehra, Niven
    Figueiredo, Ines
    Crespo, Mateus
    Riisnaes, Ruth
    Miranda, Susana A. A.
    Ferreira, Ana
    Tunariu, Nina
    Perez-Lopez, Raquel
    Boysen, Gunther
    Sharp, Adam
    Bianchini, Diletta
    Kolinsky, Michael
    Rescigno, Pasquale
    Zafeiriou, Zafeiris
    Mateo, Joaquin
    De Bono, Johann S.
    LABORATORY INVESTIGATION, 2016, 96 : 251A - 251A
  • [8] Regulation of miR-200c and miR-141 by Methylation in Prostate Cancer
    Lynch, Seodhna M.
    O'Neill, Karla M.
    McKenna, Michael M.
    Walsh, Colum P.
    McKenna, Declan J.
    PROSTATE, 2016, 76 (13): : 1146 - 1159
  • [9] Exosomal miR-1290 as a predictive biomarker for docetaxel response in metastatic castration resistant prostate cancer (mCRPC).
    Shenoy, Niraj Konchady
    Wang, Liang
    Huang, Chiang-Ching
    Kohli, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Bilusic, Marijo
    Karzai, Fatima
    Cordes, Lisa M.
    Strauss, Julius
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345